Evidence map›Paper›PMID 39497823›Full record

ArticleFrontiers in immunology2024

Cytokine production in an

Daria A Vorobyeva, Daria M Potashnikova, Elena V Maryukhnich, George I Rusakovich, Anna V Tvorogova, Anna I Kalinskaya, Natalia V Pinegina, Anna V Kovyrshina, Inna V Dolzhikova, Alexander B Postnikov and 7 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Daria A Vorobyeva *Laboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education (FSBEI HE) "Russian University of Medicine" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Daria M Potashnikova *Laboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education (FSBEI HE) "Russian University of Medicine" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Elena V Maryukhnich *Laboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education (FSBEI HE) "Russian University of Medicine" of the Ministry of Health of the Russian Federation, Moscow, Russia.
George I RusakovichI.V. Davydovsky Moscow City Clinical Hospital, Moscow Department of Healthcare, Moscow, Russia.
Anna V TvorogovaI.V. Davydovsky Moscow City Clinical Hospital, Moscow Department of Healthcare, Moscow, Russia.
Anna I KalinskayaLaboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education (FSBEI HE) "Russian University of Medicine" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Natalia V PineginaLaboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education (FSBEI HE) "Russian University of Medicine" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Anna V KovyrshinaFederal Government Budgetary Institution "The National Research Center for Epidemiology and Microbiology Named After Honorary Academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Inna V DolzhikovaFederal Government Budgetary Institution "The National Research Center for Epidemiology and Microbiology Named After Honorary Academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Alexander B PostnikovHyTest Ltd, Turku, Finland.
Fedor N RozovHyTest Ltd, Turku, Finland.
Tatiana N SotnikovaI.V. Davydovsky Moscow City Clinical Hospital, Moscow Department of Healthcare, Moscow, Russia.
Dmitry Yu KannerMoscow City Oncology Hospital No 62, Moscow, Russia.
Denis Yu LogunovFederal Government Budgetary Institution "The National Research Center for Epidemiology and Microbiology Named After Honorary Academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Alexander L GintsburgFederal Government Budgetary Institution "The National Research Center for Epidemiology and Microbiology Named After Honorary Academician N.F. Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Elena J VasilievaLaboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education (FSBEI HE) "Russian University of Medicine" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Leonid B MargolisFaculty of Natural Sciences and Medicine, Ilia State University, Tbilisi, Georgia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The mechanisms of the SARS-CoV-2-triggered complex alterations in immune cell activation and production of cytokines in lung tissue remain poorly understood, in part because of the limited use of adequate tissue models that simulate the structure and cell composition of the lung Materials and methods: Lung tissue was monitored for viability and cell composition using flow cytometry and histological analysis. SARS-CoV-2 infection was verified immunohistochemically, viral loads in tissue and culture medium were monitored by qPCR. A panel of 41 cytokines was measured in culture medium using xMAP technology. Results: The explant lung tissue was viable and maintained viral infection that influenced the cytokine production. Elevated concentrations of G-CSF, GM-CSF, GRO-a, IFN-g, IL-6, IL-8, IP-10, MCP-3, MIP-1a, PDGF-AA, and VEGF, and decreased IL-1RA concentration were observed in infected tissue compared to non-infected tissue. Discussion: Our results generally reflect the data obtained in COVID-19 patients. GRO-a, IFN-g, IL-6, IL-8, MCP-1, MCP-3, and RANTES correlated with the viral load, forming a distinct pro-inflammatory cluster. Thus, our lung

Indexed as

COVID-19CytokinesLungSARS-CoV-2Viral LoadFemaleHumansMaleMiddle AgedCytokinesantiviral responseCOVID-19cytokinesex vivo modelimmune responselung explant ex vivo cultureSARS-CoV-2

Identifiers

PMID39497823
PMCPMC11532052

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.